171 related articles for article (PubMed ID: 21712708)
1. Opioid antinociception, tolerance and dependence: interactions with the N-methyl-D-aspartate system in mice.
Dykstra LA; Fischer BD; Balter RE; Henry FE; Schmidt KT; Miller LL
Behav Pharmacol; 2011 Sep; 22(5-6):540-7. PubMed ID: 21712708
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects.
Fischer BD; Ward SJ; Henry FE; Dykstra LA
Neuropharmacology; 2010 Feb; 58(2):544-50. PubMed ID: 19699755
[TBL] [Abstract][Full Text] [Related]
3. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
4. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
[TBL] [Abstract][Full Text] [Related]
5. Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959).
Fischer BD; Miller LL; Henry FE; Picker MJ; Dykstra LA
Psychopharmacology (Berl); 2008 Jun; 198(2):271-8. PubMed ID: 18392754
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2000 Dec; 295(3):1012-21. PubMed ID: 11082436
[TBL] [Abstract][Full Text] [Related]
7. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
8. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor.
Allen RM; Granger AL; Dykstra LA
J Pharmacol Exp Ther; 2003 Nov; 307(2):785-92. PubMed ID: 12975489
[TBL] [Abstract][Full Text] [Related]
9. Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception.
Fischer BD; Dykstra LA
J Pharmacol Exp Ther; 2006 Sep; 318(3):1300-6. PubMed ID: 16772537
[TBL] [Abstract][Full Text] [Related]
10. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
[TBL] [Abstract][Full Text] [Related]
11. The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats.
Allen RM; Dykstra LA
Psychopharmacology (Berl); 1999 Feb; 142(2):209-14. PubMed ID: 10102774
[TBL] [Abstract][Full Text] [Related]
12. Role of morphine maintenance dose in the development of tolerance and its attenuation by an NMDA receptor antagonist.
Allen RM; Dykstra LA
Psychopharmacology (Berl); 2000 Jan; 148(1):59-65. PubMed ID: 10663418
[TBL] [Abstract][Full Text] [Related]
13. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
Baker AK; Hoffmann VL; Meert TF
Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
[TBL] [Abstract][Full Text] [Related]
14. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat.
Redwine KE; Trujillo KA
Pharmacol Biochem Behav; 2003 Sep; 76(2):361-72. PubMed ID: 14592689
[TBL] [Abstract][Full Text] [Related]
15. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
Craft RM; Lee DA
Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
[TBL] [Abstract][Full Text] [Related]
16. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
17. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence.
Lutfy K; Parikh D; Lee DL; Liu Y; Ferrini MG; Hamid A; Friedman TC
Neuroscience; 2016 Aug; 329():318-25. PubMed ID: 27208618
[TBL] [Abstract][Full Text] [Related]
18. Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614.
Zhu H; Brodsky M; Gorman AL; Inturrisi CE
Brain Res Mol Brain Res; 2003 Jun; 114(2):154-62. PubMed ID: 12829326
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats.
Mendez IA; Trujillo KA
Psychopharmacology (Berl); 2008 Feb; 196(3):497-509. PubMed ID: 17994223
[TBL] [Abstract][Full Text] [Related]
20. Memantine and dizocilpine interactions with antinociceptive or discriminative stimulus effects of morphine in rats after acute or chronic treatment with morphine.
Chen Y; Evola M; Young AM
Psychopharmacology (Berl); 2013 Jan; 225(1):187-99. PubMed ID: 22864944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
